• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION EASYTRAK 2 IS-1; Implantable Lead

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION EASYTRAK 2 IS-1; Implantable Lead Back to Search Results
Model Number 4542
Medical Device Problem Code High impedance (1291)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/26/2026
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
If pertinent information is provided in the future, a supplemental report will be submitted.This product investigation is still in progress.This report will be updated when product investigation is complete.
 
Event or Problem Description
It was reported that this left ventricular (lv) lead exhibited a high out of range pacing impedance, greater than 3000 ohms.It was noted the patient had some other medical issues.No lv vectors were viable, subsequently, this lv lead was programmed off.This lv lead remains in situ.No additional adverse patient effects were reported.
 
Event or Problem Description
It was reported that this left ventricular (lv) lead exhibited a high out of range pacing impedance, greater than 3000 ohms.It was noted the patient had some other medical issues.No lv vectors were viable, subsequently, this lv lead was programmed off.This lv lead remains in situ.No additional adverse patient effects were reported.
 
Event or Problem Description
It was reported that this left ventricular (lv) lead exhibited a high out of range pacing impedance, greater than 3000 ohms.It was noted the patient had some other medical issues.No lv vectors were viable, subsequently, this lv lead was programmed off.This lv lead remains in situ.No additional adverse patient effects were reported.Additional information was received.This lead was surgically abandoned and replaced.No additional adverse patient effects were reported.
 
Additional Manufacturer Narrative
Device technical analysis: this product has not been returned to boston scientific, and as a result, a laboratory analysis could not be conducted.A review of the device history record (dhr) was performed.The review of the dhr identified that there were no process related non-conformances, scrap, or rework performed during the production that could explain the event.The reviews ensure each device meets specification prior to release for use.There is no indication the device manufacturing process contributed to the reported complaint.A risk review was completed and confirmed that the event of pacing impedance high out of range was defined in the risk documentation.This event type has been accounted for during product risk analysis to support acceptable risk benefit for the product.Review of labeling determined that the complaint situation was listed in the manual.There was no indication in the complaint that the product was not used in accordance to labeling.The manual was unlikely to be the cause of the reported complaint; translation, wording, or graphics does not require further review.Investigation conclusion: based on a thorough review of the reported complaint, boston scientific has assigned an investigation conclusion code of cause not established.
 
Additional Manufacturer Narrative
Additional information added to b5.F10 and h6 updated.Device technical analysis: this product has not been returned to boston scientific, and as a result, a laboratory analysis could not be conducted.A review of the device history record (dhr) was performed.The review of the dhr identified that there were no process related non-conformances, scrap, or rework performed during the production that could explain the event.The reviews ensure each device meets specification prior to release for use.There is no indication the device manufacturing process contributed to the reported complaint.A risk review was completed and confirmed that the event of pacing impedance high out of range was defined in the risk documentation.This event type has been accounted for during product risk analysis to support acceptable risk benefit for the product.Review of labeling determined that the complaint situation was listed in the manual.There was no indication in the complaint that the product was not used in accordance to labeling.The manual was unlikely to be the cause of the reported complaint; translation, wording, or graphics does not require further review.Investigation conclusion: based on a thorough review of the reported complaint, boston scientific has assigned an investigation conclusion code of cause not established.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EASYTRAK 2 IS-1
Common Device Name
Implantable Lead
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
Boston Scientific Corporation
road 698, lot no. 12
dorado PR 00646 -260
PR   00646-2602
Manufacturer Contact
mark mischke
4100 hamline avenue north
saint paul, MN 55112
+1(612)875-7234
MDR Report Key25610801
Report Number2124215-2026-33558
Device Sequence Number18592419
Product Code NIK
UDI-Device Identifier00802526410901
UDI-Public(01)00802526410901(17)110120
Combination Product (Y/N)Y
Initial Reporter StateNC
Initial Reporter CountryUS
PMA/510(K) Number
P010012
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2009
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date (Section B) 09/30/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date01/20/2011
Device Model Number4542
Device Catalogue Number4542
Device Lot Number130437
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/29/2026
Supplement Date Received by Manufacturer09/03/2026
09/18/2026
Initial Report FDA Received Date06/24/2026
Supplement Report FDA Received Date09/09/2026
09/30/2026
Date Device Manufactured01/20/2009
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention; Hospitalization;
Patient Age64 YR
Patient SexFemale
-
-